Press News

Press News

Press News | 26.09.2024

Print:
Title Media Publ. Date
Marios Themistokleous: At the end of 2025, the digital oncology patients record will be completed Daily PharmaNews 25/09/2024
Strengthening the pool of personal doctors Καθημερινή 26/09/2024
Kavita Patel: Pharmaceutical innovation is an investment for the future Καθημερινή 26/09/2024
Personal pediatricians for 530,000 children Τα Νέα 26/09/2024

 

See here the publicity

 

Web Monitoring Report for the period 25/09 – 26/09

Title Media Publ. Date
In the RRF, the upgrading of citizen services in the Health system amna.gr 25/09/2024
Why GP reform has failed – Only 6% of doctors choose general practice capital.gr 26/09/2024
When the innovation of a treatment reduces cancer deaths and metastases cnn.gr 26/09/2024
Ad. Georgiadis on ERTNews: 9/10 of medicine shortages have been covered ertnews.gr 26/09/2024
D. Evgenidis on ERTNews: EOPYY’s mistake with expensive medicines burdens the insured – The correction is coming immediately ertnews.gr 25/09/2024
Personal doctor: How will EOPYY, public and freelance doctors be paid – When will citizens pay healthreport.gr 26/09/2024
One in 4 lives despite the cancer and without relapses with immunotherapy in.gr 26/09/2024
Cancer: The early use of innovative treatments ensures health and also savings in the NHS moneyreview.gr 26/09/2024
Wegovy and Ozempic: Weight loss comes cheaper in Europe naftemporiki.gr 25/09/2024
New episode in the fight over medicines – What do the wholesalers attribute to the PFS? news4health.gr 25/09/2024
Free pediatric coverage for 500,000 children and incentives for GPs – The draft law on primary care newsbomb.gr 25/09/2024
Pharmaceutical innovation: Giving many healthy years of life to European citizens – What is Greece’s position? ygeiamou.gr 26/09/2024

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.